SAB Biotherapeutics Inc (SABS)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
299,345,000
EV to revenue ratio (TTM)
1.206
EV to ebitda
64.16
Financial Performance
Revenue (TTM)
114,700
Gross profit (TTM)
-48,268,332
EBITDA
-68,707,776
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-33.50%
Return on equity (TTM)
-11.30%
Per Share Metrics
Revenue per share (TTM)
0.01
EPS
0.24
Diluted EPS (TTM)
0.24
Book value
2.57
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
13.71
Trailing P/E
13.71
Forward P/E
PEG ratio
Price to sales ratio (TTM)
2.959
Price to book ratio (TTM)
1.483
Growth
Quarterly earnings growth (YoY)
-62.40%
Quarterly revenue growth (YoY)
-60.00%
Analyst Sentiment
Strong buy
1
Buy
10
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.538